KochovskaS, EkstromM, Hansen-FlaschenJ, et al.Hiding in plain sight—The evolving definition of chronic breathlessness and new ICD-11 wording. Eur Respir J, 2023; 61(3):2300252; doi: 10.1183/13993003.00252-2023
4.
KochovskaS, BrunelliVN, CurrowD. The invisibility of chronic breathlessness. Why don’t we talk about the symptom? Curr Opin Support Palliat Care, 2025; 19(2):77–82; doi: 10.1097/SPC.0000000000000759
5.
WolkoveN, DajczmanE, ColaconeA, et al.The relationship between pulmonary function and dyspnea in obstructive lung disease. Chest, 1989; 96(6):1247–1251.
6.
TzanakisN, SamiouM, LambiriI, et al.Evaluation of health-related quality-of-life and dyspnea scales in patients with idiopathic pulmonary fibrosis. Correlation with pulmonary function tests. Eur J Intern Med, 2005; 16(2):105–112.
7.
FletcherCM. Standardised questionnaire on respiratory symptoms: A statement prepared and approved by the MRC committee on the aetiology of chronic bronchitis (MRC breathlessness score). BMJ, 1960; 2(5213):1665.
8.
ManaliED, LyberopoulosP, TriantafillidouC, et al.MRC chronic dyspnea scale: Relationships with cardiopulmonary exercise testing and 6-minute walk test in idiopathic pulmonary fibrosis patients: A prospective study. BMC Pulm Med, 2010; 10:32; doi: 10.1186/1471-2466-10-32
9.
BestallJC, PaulEA, GarrodR, et al.Usefulness of the medical research council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax, 1999; 54(7):581–586; doi: 10.1136/thx.54.7.581
10.
YorkeJ, MoosaviSH, ShuldhamC, et al.Quantification of dyspnoea using descriptors: Development and initial testing of the dyspnoea-12. Thorax, 2010; 65(1):21–26.
11.
BanzettRB, O’DonnellCR, GuilfoyleTE, et al.Multidimensional dyspnea profile: An instrument for clinical and laboratory research. Eur Respir J, 2015; 45(6):1681–1691.
12.
JonesPW, HardingG, BerryP, et al.Development and first validation of the COPD assessment test. Eur Respir J, 2009; 34(3):648–654.
13.
BjellandI, DahlAA, HaugTT, et al.The validity of the hospital anxiety and depression scale: An updated literature review. J Psychosom Res, 2002; 52(2):69–77.
14.
MahlerDA, WellsCK. Evaluation of clinical methods for rating dyspnea. Chest, 1988; 93(3):580–586; doi: 10.1378/chest.93.3.580
15.
WilliamsMT, LewthwaiteH, PaquetC, et al.Dyspnoea-12 and multidimensional dyspnea profile: Systematic review of use and properties. J Pain Symptom Manage, 2022; 63(1):e75–e87; doi: 10.1016/j.jpainsymman.2021.06.023
16.
ChengC, TakemuraN, ReddelHK, et al.Prevalence and correlates of breathlessness in adults: An umbrella review and updated systematic review with meta-analysis in general and clinical populations. Eur Respir Rev, 2025; 34(178):250104.
17.
MarciniukDD, GoodridgeD, HernandezP, et al.; Canadian Thoracic Society COPD Committee Dyspnea Expert Working Group. Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: A Canadian thoracic society clinical practice guideline. Can Respir J, 2011; 18(2):69–78; doi: 10.1155/2011/745047
18.
BudhwarN, SyedZ. Chronic dyspnea: Diagnosis and evaluation. Am Fam Physician, 2020; 101(9):542–548.
